Table 2.
Incidence of any and all musculoskeletal morbidities among adults with and without SCI with one-year clean enrollment period.
| Spinal Cord Injury | † No Outcome at Baseline | |
|---|---|---|
| Case/Denominator | Control/Denominator | |
| Any Musculoskeletal | 2518/3057 (82.4%)* | 511657/1077396 (47.5%) |
| Osteoarthritis | 2659/6620 (40.2%)* | 249195/1342834 (18.6%) |
| Osteoporosis | 1760/7338 (24.0%)* | 88662/1421643 (6.2%) |
| Pathologic fracture | 1543/7648 (20.2%)* | 20965/1469029 (1.4%) |
| Disorders of muscle, joint, ligaments, tendons, and connective tissues | 3375/4382 (77.0%)* | 514011/1163784 (44.2%) |
| Sarcopenia and weakness | 2540/8177 (31.1%)* | 90152/1456285 (6.2%) |
| Myalgia | 1310/8311 (15.8%)* | 119512/1422838 (8.4%) |
| Rheumatoid arthritis, myositis, and musculoskeletal infections | 414/8724 (4.7%)* | 29099/1455696 (2.0%) |
P<.01 and standard mean difference (SMD) ≥0.2
Denominators for both cases and controls reflect a one-year clean period during their enrollment for the specific condition. For instance, among cases (SCI), there exist 6,620 patients whose first year of enrollment had no evidence of osteoarthritis; therefore, inferred incident osteoarthritis could be estimated for this subset of the full SCI cohort. As a result, all patient cohorts’ denominators dynamically change conditional on the incident outcome being measured to ensure a clean period in the first year of enrollment.